Lv41
620 积分 2021-07-27 加入
Multimodal clocks of human aging
5小时前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
1个月前
已完结
Impacts of ageing on the efficacy of CAR-T cell therapy
3个月前
已完结
T cell exhaustion and senescence for ovarian cancer immunotherapy
3个月前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
4个月前
已完结
CAR-T therapy in solid tumors
6个月前
已完结
Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
7个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
8个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
8个月前
已完结
皖公网安备34019202002308
